Therapeutic Forum

Do Alpha-agonists and LASIK Mix?

Christopher J. Quinn, O.D.

Some doctors have suggested that Alphagan (brimonidine) may have neuroprotective properties as well the ability to lower intraocular pressure in the management of glaucoma.

Others have pointed to the transient increase in IOP that occurs when the surgeon applies suction to the microkeratome during refractive surgery. They say this may induce glaucoma-like optic nerve damage. (See “Does LASIK Damage the Nerve Fiber Layer?” News Review, January 2000.)

Both hypotheses are tentative at best. Until they are proven through rigorous scientific evaluation, it’s probably not prudent to change our clinical practice patterns.

Complications Arise
Nevertheless, in response to the theorized optic nerve damage that may occur during LASIK and because some evidence has been presented that Alphagan has neuroprotective properties, some surgeons have incorporated the routine use of Alphagan as a preoperative treatment for LASIK.

But as this treatment became briefly popular, a number of other complications associated with the use of Alphagan surfaced. The most significant was an apparent increase in the number of cases of flap slippage. Refractive surgeons have observed flap slippage the day following LASIK.1,2 It’s easy to recognize flap slippage following LASIK because the flap shrivels and bunches at the hinge. Patients complain of poor vision and pain the day following surgery.

The flap slippage occurs due to poor adhesion between the flap and underlying corneal bed, which probably results from poor endothelial cell function. Corneal endothelial cells create an osmotic gradient that maintains the cornea in a state of relative dehydration. If the endothelial cells don’t function adequately, the flap may not properly adhere to the corneal stroma. Slippage may also occur if the ocular surface is too dry and the flap instead adheres to the eyelid, resulting in mechanical flap dislocation.

Treatment Succeeds
Fortunately, surgeons can treat most cases of flap slippage successfully. The surgeon can “refloat” the flap, re-dry the cornea, and then place a bandage contact lens on the eye to protect to the flap and prevent recurrence. Patients still can achieve excellent visual results, although the best results occur if the surgeon repairs the flap as soon as possible following surgery.

So if alpha-agonists are associated with flap slippage, do they have any role in refractive surgery? Not as neuroprotective agents, but they probably do for other reasons. Indeed, alpha-agonists are effective in dehydrating the conjunctiva, and they are also powerful vasoconstrictors that don’t induce significant papillary dilation.

In patients who have peripheral corneal neovascularization who would otherwise bleed following the creation of the LASIK flap, pretreatment with Alphagan or Iopidine (apraclonidine) results in rapid vasoconstriction and prevents bleeding during the procedure. This is particularly useful in cases where a large flap may impinge on these peripheral corneal blood vessels.

Alphagan or Iopidine may help when the surgeon has difficulty obtaining suction with the microkeratome because the patient has a thick or boggy conjunctiva. These drugs can dehydrate the conjunctiva so that the microkeratome achieves appropriate suction and the surgeon can make a successful microkeratome pass.

Neuroprotection may be the Holy Grail of glaucoma management, but its day has not yet come, and it certainly is not ready for prime time in refractive surgery. u

Thanks to Brian Den Beste, O.D., Orlando, Fla., for his input and expertise on this topic.

  1. Walter KA. Adverse effect of Alphagan on LASIK flap adherence. American Society of Cataract and Refractive Surgery Abstracts May 2000;155.
  2. Talamo JH, de Luise VP. Increased incidence of flap slippage after LASIK associated with the use of preoperative Alphagan. American Society of Cataract and Refractive Surgery Abstracts May 2000;155. Rk, Ab

top

Return to October 2000 Highlights
 

© Review of Optometry OnLine
October 15, 2000
| | | | | |